Electromagnetic tomography uses nonionizing electromagnetic radiation to differentiate between human tissues. Using a unique antenna design, we create a complex electromagnetic field that interacts with a biological object. This interaction changes the electromagnetic field which is further measured by sensors and analyzed by a set of sophisticated, proprietary algorithms.

The contrasts in the dielectric properties of various tissues enable us to detect functional and pathological conditions, including (but not limited to) malignancies in the breast, liver, and lung; tissue blood content or flow; hypoxia; ischemia; infarction; compartmental injury; stroke; and brain trauma.

EMTensor technology roadmap envisages the further miniaturization of device and development of its own system-on-chip. The cost of the bill of materials will be decreased dramatically in 3 years.

The technology roadmap and R&D spend to support the Company’s clinical applications roadmap planned in details for the next three years.

During the last seven years, EMTensor has developed four generations of brain scanning devices with the non-incremental improvements in each generation. A product development cycle takes around 1.5 years.

If you are interested in getting involved in our clinical trials please contact us at office@emtensor.com.